1317 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 27 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNAB1Potassium voltage-gated channel subfamily A member regulatory beta subunit 1Predicted intracellular proteins
Transporters
Tissue enhanced
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium voltage-gated channel modifier subfamily F member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatusTissue enriched
KCNH1Potassium voltage-gated channel subfamily H member 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enriched
KCNH2Potassium voltage-gated channel subfamily H member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH3Potassium voltage-gated channel subfamily H member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleus
Mitochondria
Group enriched
KCNIP4Potassium voltage-gated channel interacting protein 4Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ10Potassium voltage-gated channel subfamily J member 10Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ11Potassium voltage-gated channel subfamily J member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ13Potassium voltage-gated channel subfamily J member 13Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ16Potassium voltage-gated channel subfamily J member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesGroup enriched
KCNJ2Potassium voltage-gated channel subfamily J member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ3Potassium voltage-gated channel subfamily J member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ5Potassium voltage-gated channel subfamily J member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ6Potassium voltage-gated channel subfamily J member 6Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium voltage-gated channel subfamily J member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK15Potassium two pore domain channel subfamily K member 15Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK16Potassium two pore domain channel subfamily K member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK17Potassium two pore domain channel subfamily K member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium two pore domain channel subfamily K member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK5Potassium two pore domain channel subfamily K member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
NucleusTissue enhanced
KCNK6Potassium two pore domain channel subfamily K member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol
Mixed
KCNK9Potassium two pore domain channel subfamily K member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNMB1Potassium calcium-activated channel subfamily M regulatory beta subunit 1Predicted membrane proteins
Transporters
Tissue enhanced
KCNMB2Potassium calcium-activated channel subfamily M regulatory beta subunit 2Predicted membrane proteins
Transporters
Tissue enhanced
KCNMB3Potassium calcium-activated channel subfamily M regulatory beta subunit 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Mitochondria
Mixed
KCNN2Potassium calcium-activated channel subfamily N member 2Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNN4Potassium calcium-activated channel subfamily N member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel subfamily Q member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel subfamily Q member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium voltage-gated channel subfamily Q member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNQ4Potassium voltage-gated channel subfamily Q member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNS1Potassium voltage-gated channel modifier subfamily S member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS2Potassium voltage-gated channel modifier subfamily S member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel modifier subfamily S member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatus
Plasma membrane
Cytosol
Tissue enhanced
KCNT1Potassium sodium-activated channel subfamily T member 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNT2Potassium sodium-activated channel subfamily T member 2Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enhanced
KDELR1KDEL endoplasmic reticulum protein retention receptor 1Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Expressed in all
KISS1RKISS1 receptorDisease related genes
G-protein coupled receptors
Potential drug targets
Predicted membrane proteins
Transporters
Vesicles
Plasma membrane
Tissue enriched
KLKlothoDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
KLBKlotho betaPredicted membrane proteins
Transporters
Tissue enhanced
KPNA1Karyopherin subunit alpha 1Predicted intracellular proteins
Transporters
Nucleus
Cytosol
Expressed in all
KPNA2Karyopherin subunit alpha 2Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
KPNA3Karyopherin subunit alpha 3Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
KPNA4Karyopherin subunit alpha 4Predicted intracellular proteins
Transporters
NucleusExpressed in all
« prev | Page of 27 | next »